进步的代价：了解处方药的创新和可负担性。

IF 2.5 4区医学 Q2 HEALTH CARE SCIENCES & SERVICES

American Journal of Managed Care Pub Date : 2024-10-01 DOI:10.37765/ajmc.2024.89615

Anthony T Lo Sasso, M Christopher Roebuck

引用次数: 0

摘要

经济激励和专利保护推动着创新药物的开发。药品价格由消费者需求而非生产成本决定。因此，政府监管会给未来的研发投资带来风险。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

The price of progress: understanding innovation and affordability of prescription drugs.

Economic incentives and patent protections drive development of innovative medications. Drug prices are determined by consumer demand, not production costs. Therefore, governmental regulation risks future investment in research and development.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

American Journal of Managed Care 医学-卫生保健

CiteScore

3.60

自引率

0.00%

发文量

177

审稿时长

4-8 weeks

期刊介绍： The American Journal of Managed Care is an independent, peer-reviewed publication dedicated to disseminating clinical information to managed care physicians, clinical decision makers, and other healthcare professionals. Its aim is to stimulate scientific communication in the ever-evolving field of managed care. The American Journal of Managed Care addresses a broad range of issues relevant to clinical decision making in a cost-constrained environment and examines the impact of clinical, management, and policy interventions and programs on healthcare and economic outcomes.